Skip to main content

Peer Review reports

From: Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma

Original Submission
25 Nov 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
30 Dec 2023 Reviewed Reviewer Report
17 Jan 2024 Reviewed Reviewer Report
3 Mar 2024 Author responded Author comments - Arash O. Naghavi
Resubmission - Version 3
3 Mar 2024 Submitted Manuscript version 3
19 Mar 2024 Author responded Author comments - Arash O. Naghavi
19 Mar 2024 Reviewed Reviewer Report
Resubmission - Version 4
19 Mar 2024 Submitted Manuscript version 4
20 Mar 2024 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
20 Mar 2024 Editorially accepted
9 Apr 2024 Article published 10.1186/s12885-024-12151-7

You can find further information about peer review here.

Back to article page